In hepatocellular carcinoma (HCC), ADAR1-induced amino acid substitution in antizyme inhibitor 1 (AZIN1) enhances its activity and promotes tumor initiation and development 111. The gene discussed is ADAR; the disease is hepatocellular carcinoma.